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Simultaneous infection by multiple parasite species is ubiquitous in nature.
Interactions among co-infecting parasites may have important consequences
for disease severity, transmission and community-level responses to pertur-
bations. However, our current view of parasite interactions in nature comes
primarily from observational studies, which may be unreliable at detecting
interactions. We performed a perturbation experiment in wild mice, by
using an anthelminthic to suppress nematodes, and monitored the con-
sequences for other parasite species. Overall, these parasite communities
were remarkably stable to perturbation. Only one non-target parasite species
responded to deworming, and this response was temporary: we found
strong, but short-lived, increases in the abundance of Eimeria protozoa,
which share an infection site with the dominant nematode species, suggesting
local, dynamic competition. These results, providing a rare and clear exper-
imental demonstration of interactions between helminths and co-infecting
parasites in wild vertebrates, constitute an important step towards under-
standing the wider consequences of similar drug treatments in humans
and animals.
1. Introduction
Co-infection, where an individual host harbours multiple parasite species, is the
rule rather than the exception in nature, and has been documented across
diverse systems [1,2]. The parasites infecting an individual host can be
viewed as an ecological community, within which species may interact directly
through chemical or physical interference, indirectly via ‘bottom-up’ proces-
ses (e.g. competition for shared host resources) or indirectly via ‘top-down’
processes (e.g. immune-mediated competition or facilitation) [3].
Such interspecific interactions are an important determinant of how com-
munities respond to external events. Specifically, the number, strength and
arrangement of interactions among species will affect community stability in
the face of perturbations (i.e. the removal or addition of organisms of a particular
species) [4–6].Many interactions, strong interactions and feedback loops all result
in relatively unstable communities with both low resistance (perturbations have a
large effect) and low resilience (long recovery times after perturbation) [4].
Furthermore, if the perturbed species is involved in many strong interactions
with other species (i.e. it is a keystone species), then larger and more prolonged
effects are expected than if the perturbed species has few or weak links to other
species [7]. These and other determinants of stability arewell researched in several
& 2013 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.
types of ecological network, such as free-living food webs [8],
but the stability of within-host–parasite communities to
perturbation has yet to be assessed.
Understanding parasite interactions and the effects of per-
turbations is particularly important in disease ecology. A
change in the abundance of a target parasite species, for
example as a result of drug administration, could affect
other (non-target) parasites in the same host, negatively or
positively affecting host health depending on the type of
parasite interaction. Thus, knowledge about the stability of
within-host–parasite communities, and how interactions
within them determine this, is highly valuable in both
pure and applied disease research, and may be especially
important for designing optimal treatment or vaccination
strategies in co-infected populations.
Although within-host interactions between parasite
species have frequently been demonstrated in laboratory
experiments [9,10], these studies often use artificial infection
regimes (e.g. single doses, often leading to infections of un-
naturally high intensity), usually consider just two parasite
species, and hosts are typically homogeneous (e.g. same sex
and strain) and fed ad libitum, all of which will affect the
relevance of these studies for natural host–parasite commu-
nities. Studies of wild hosts are therefore highly desirable.
Conclusions from observational studies in wild populations
have been mixed, with some suggesting within-host–parasite
communities contain many strong interactions among species
[11,12], whereas others conclude they are near-random assem-
blages with little structure and few interactions [13,14].
However, a well-known issue with observational approaches
is that statistical associations between species may arise
through a range of processes other than interspecific inter-
action [15]. For instance, for parasite species, this could
involve covariance in exposure owing to host age or a shared
transmission route. While one can attempt to control for con-
founding factors, the extent to which observed associations
reflect true within-host–parasite interactions remains uncer-
tain [16]. In free-living community ecology, manipulative
(perturbation) field experiments are widely recognized as the
most reliable way of measuring interspecific interactions and
evaluating community stability [17]. For parasite communities,
randomized, controlled treatment experiments constitute a
powerful tool for measuring the strength of within-host–para-
site interactions, assessing the timescale over which they
operate, and directly measuring the stability of natural parasite
communities to perturbations. However, they have rarely been
adopted for examining within-host–parasite interactions (but
see references [18,19]).
Here, we adopt a perturbation experimental approach to
study natural within-host–parasite communities of wild
wood mice (Apodemus sylvaticus). Our aims are twofold: (i) to
determine the strength and nature of interactions among para-
site species within these communities, and (ii) to assess the
stability of these within-host communities to perturbation.
We used the anthelminthic drug Ivermectin to reduce levels
of nematode infection (the target parasite), and a longitudinal
design to track the effects of this perturbation on both target
and non-target parasites over the following weeks. Nematodes
are an ideal target for such a perturbation experiment, as they
are an abundantmember of natural woodmouse parasite com-
munities, and are well known for their immunomodulatory
effects, in particular, their suppression of adaptive immune
responses [20]. Consequently, nematodes may constitute
keystone members of parasite communities, able to interact
with many co-infecting parasites via the host’s immune
system [9,10,21] or by competition for resources in the gastro-
intestinal (GI) tract [22]. Thus, nematodes are expected to
havemany strong interactionswith other parasites and, if para-
site communities are relatively unstable, perturbing this group
should have dramatic consequences for co-infecting parasite
community members. Our experiment presents a first explicit
test of these hypotheses.
2. Material and methods
(a) Field experiment
Between May and December 2010, wood mice were trapped on
five 0.5 ha grids in two woodlands in Cheshire (two grids in
Manor Wood, 538190 N, 3830 W; three grids in Haddon Wood,
538160 N, 3810 W). An overview of the experimental design is
given in the electronic supplementary material, figure S1. On
each grid, two live traps (H. B. Sherman 2  2.5  6.5 inch fold-
ing trap, Tallahassee, FL, USA) baited with grain and bedding
material were placed every 10 m in a 70  70 m square (total
128 traps per grid). Primary trapping was monthly: during the
first three weeks of every month, two grids were trapped each
week for three consecutive nights. At first capture, all mice
were tagged using a subcutaneous microchip transponder for
identification. On each grid, mice were rotationally assigned to
one of three treatments at first capture: either repeated or
single treatment with the anthelminthic Ivermectin, or a control
treatment. Mice in the repeated Ivermectin treatment group
received 10 mg kg21 Ivermectin orally every primary trapping
session (i.e. monthly, if captured every month). Those in the
single-treatment group received this dose at first capture but
water at subsequent captures. Control mice received water at
every monthly capture. The two different treatment regimes
were designed to test the impact of both a ‘press’ and a ‘pulse’
perturbation on parasite communities [17]. Ivermectin is a
potent anti-nematode drug and is also known to affect some
arthropods; however, we found no evidence that Ivermectin
affected common ectoparasites on wood mice in this study (see
electronic supplementary material, section S1). Ivermectin is
not known to have direct effects on any other types of parasite.
During the monthly primary trapping sessions, morphometric
data were taken from all mice (age, sex, body mass, body
length and reproductive condition), and a faecal and blood
sample (from the tail tip) collected. Fur was also brushed to
record tick and flea presence. Faecal samples were weighed
and stored in 10 per cent formalin solution until parasite identi-
fication. During the last week of June, August and October, all
experimental grids were trapped for an additional two consecu-
tive nights each (secondary trapping, at which no treatments were
given), permitting the collection of faeces from mice treated one
to three weeks previously in a primary trapping session, and
thus assessment of GI parasite responses to treatment over time-
scales shorter than a month (blood parasite data were available
only for primary trapping sessions). GI parasites were detected
using the salt flotation technique [22], and two blood parasite
genera were screened for and identified using PCR-based diagno-
stics: bacteria of the genus Bartonella [23,24] and trypanosomes [25]
(see the electronic supplementary material, section S2).
(b) Statistical analysis of treatment effects
For parasites where infection was quantified by faecal egg counts
(GI parasites such as nematodes and Eimeria spp.), two lines of
reasoning motivated us to perform separate analyses of infection
probability (parasite presence–absence) and infection intensity
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(log-transformed number of eggs/oocysts per gram faeces among
infected individuals). First, the effects of treatment, and any
revealed interspecific parasite interactions, could, in principle,
arise from several biological processes affecting either (i) the prob-
abilityof infection (e.g. through parasite establishment or clearance
via drugs) and/or (ii) the success of parasites once inside the host,
reflected either through parasite fecundity (for helminths), or repli-
cation ability (for microparasites such as Eimeria protozoa).
Separate statistical analyses of infection probability and intensity
allow us to tease apart these potential processes. Second, this
analysis strategy was supported by results from zero-inflated
negative binomial (ZINB) models [26] on egg/oocyst counts
measured shortly after treatment (one to three weeks later; see
§3). ZINB models allowed us to test whether treatment affected
one or both of two statistical processes: a negative binomial
count process, which accounts for the typically observed aggre-
gated distribution in parasite egg/oocyst counts, and a zero-
inflation process by which additional zero counts (i.e. individuals
who are uninfected or who have been cleared of infection) are gen-
erated. By comparing the fit of a ZINB model with a standard
negative binomial generalized linear model (GLM) for both
nematodes and Eimeria spp., we testedwhether the data suggested
a need to consider effects on infection probability and parasite
count separately, or whether a single negative binomial count
process better represented the data. For both parasite groups,
which had highly aggregated distributions with many zero counts
(see the electronic supplementary material, figure S2), zero-inflated
models provided a significantly better fit than the equivalent nega-
tive binomial models and suggested that, in the short-term,
treatment haddifferential effects on a count and a zero-inflation pro-
cess (see §3 and electronic supplementarymaterial, section S3a). For
bloodmicroparasites (Bartonella bacteria and trypanosomes), where
infection load could not be quantified,we tested treatment effects on
infection probability using binomial GLMs, to assess whether treat-
ment altered susceptibility to infection.
We analysed the effect of Ivermectin on target (nematodes) and
non-target parasites in mice from the experimental grids over
several timescales (one to three, four and eight weeks after first
treatment), usingGLMs in R v. 2.13 [27]. Allmodelswere performed
with the glm function, with infection probability models using a
binomial error distribution, whereas intensity models used a Gaus-
sian error distribution. Parasite species from the same genera were
pooled in the main analyses, but species with prevalence more
than 10 per cent were also analysed individually where data
permitted (table 1).
In all models, treatment was represented either as a two-level
factor (‘drug’: yes (including repeated and single treatments) or
no) over timescales before treatments diverged (up to one
Table 1. The prevalence and infection site of gastrointestinal (GI) and blood parasites found in wood mouse samples taken during the parasite community
perturbation experiment. Taxonomic groups of parasites whose prevalence exceeded 10% (shown in italics) were used as response variables in statistical
analyses.
site of infection prevalence (%) mean eggs/oocysts per gram faeces
macroparasites
nematodes GI tract 46.78 40 (range 0–673)
Heligmosomoides polygyrus (upper ileum) 42.03 33 (range 0–563)
Syphacia stroma (throughout tract) 5.42
Aonchotheca murissylvatici 1.70
Nematode sp. 1a 2.27
Aspiculuris sp. 0.87
Cestodes GI tract 6.78
Hymenolepsis sp. 3.05
Cestode sp. 1a 1.02
Cestode sp. 2a 3.05
microparasites
Eimeria spp. GI tract 46.10 5448 (range 0–182 400)
E. hungaryensis (Upper ileum) 30.17 2876 (range 0–181 000)
E. apionodes (Lower ileum) 14.92 1625 (range 0–177 100)
Eimeria sp. 1a 9.83
E. uptoni 2.03
Bartonella spp. vascular endothelium, followed by
invasion of red blood cells
58.07
B. doshiae-like 9.72
B. grahamii 18.98
B. taylorii 31.94
B. birtlesii 7.87
BGA 0.93
Trypanosoma grosi bloodstream (extracellular) 12.09
aParasites marked could not be identiﬁed to a lower taxinomic level based on egg/oocyst morphology alone.
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month after first capture), or as a three-level factor (‘treatment’:
single, repeated or control) for timescales where treatment
groups differed (more than a month after first capture). For GI
parasites, data from secondary trapping sessions were used to
test for short-term effects of Ivermectin treatment (within three
weeks of treatment), whereas longer-term treatment effects
were tested at one and two months after first capture. For
blood parasites, treatment effects were examined one and two
months after first capture. Interaction terms between treatment
and initial nematode status were examined, where initial nema-
tode status was taken as infection status at first capture (for
primary trapping data collected four and eight weeks after first
capture), or infection status one to threeweeks previously (for sec-
ondary trapping data). Relevant covariates were fitted in all
models where appropriate: trapping grid (five-level factor),
month of capture (factor), host age (three-level factor: juveniles,
subadults and adults), host sex and faecal sample mass (continu-
ous) or DNA concentration (continuous). Reproductive status
was coded as a binary variable with animals deemed reproduc-
tively active if they had descended or protruding testes (males),
were pregnant or had a perforate vagina (females).
We also tested whether treatment affected total within-host–
parasite species richness (GI and blood parasites combined at
monthly trapping sessions), orGI richness (at all trapping sessions),
over the same timescales outlined earlier. Inmodels of parasite rich-
ness, overdispersion was accounted for (if required) by using a
quasi-Poisson model. All starting models were simplified by back-
ward stepwise elimination of non-significant terms (p. 0.05)
beginning with interactions, to obtain the minimum adequate
model.We compared these resultswith those from anAkaike infor-
mation criteria-based model selection approach [28] to
confirm findings were robust tomodel selectionmethod (electronic
supplementary material, section S3b). Full details of covariates
included in each starting model, and terms remaining in the
minimal model after simplification, are given in electronic
supplementary material, table S4.
(c) Calculation of treatment effect sizes
An effect size (Hedge’s g, the standardized mean difference) was
calculated to measure the magnitude and direction of nematode
treatment effect for each parasite species-specific response variable.
This was performed on two timescales: (i) to measure immediate
effects of treatment, one to three weeks after the last treatment
was given (secondary trapping data), and (ii) four weeks after
first capture. For Eimeria oocyst intensity (log-transformed),
means and standard deviations in the control and treated groups
were used to directly calculate g [29]. For infection probability,
the odds ratio (OR) was first calculated, then standard conversion
calculations [29] were used to derive Hedge’s g from the OR, so
effect sizes for parasite intensity and infection probability responses
were on a common scale.
3. Results
The wood mice in these populations harboured a diverse
community of parasites (table 1), with individuals being sim-
ultaneously infected with up to six parasite species at any one
time (mean within-host–species richness ¼ 2.09), and 66 per
cent of individuals co-infected. Overall, 146 mice in the exper-
iment were captured a total of 312 times, with a mean
number of captures per mouse of 2.14 (range 1–8). Few initial
differences between treatment groups in parasite response
variables were present, though these were found for Eimeria
hungaryensis and pooled Bartonella spp. infection probability,
as well as Eimeria apionodes intensity (see the electronic
supplementary material, table S1).
(a) Effect of anti-nematode treatment on target
parasites
Anthelminthic treatment had a clear negative effect on
nematodes (the target parasites; figure 1a). A ZINB model
of nematode egg counts one to three weeks after treatment
provided a better fit to the data than a standard negative
binomial model (Vuong test, p ¼ 0.008). This result suggests
that shortly after treatment, egg counts were better rep-
resented by the combination of a count process and an
additional zero-generating process (i.e. individuals clearing
their nematode infection), rather than a count process alone.
This ZINB model revealed a strong effect of Ivermectin
on the probability of being uninfected post-treatment
(OR ¼ 10.03 of a zero count for treated compared with
untreated mice; normal 95% CI: 2.30, 43.77), but weaker
evidence that treatment reduced egg count (incidence rate
ratio, IRR ¼ 0.379 for treated compared with untreated mice,
normal 95%CI: 0.121, 1.183; electronic supplementarymaterial,
section S3a). In line with the ZINB model results, a binomial
model of infection probability (which controlled for more cov-
ariates as shown in electronic supplementary material, table
S2) showed that treatedmice had a 71 per cent lower probability
of infection three weeks after treatment compared with control
mice (figure 1a; electronic supplementary material, table S2;
drug: x21 ¼ 15.52, p, 0.001, n ¼ 42). Post hoc tests revealed
no evidence that the treatment effect of reduced infection
probability varied between months, across host age groups
(adult versus subadult), with body mass or with reproduc-
tive status (drugmonth x21¼ 0.50, p ¼ 0.479; drug  age
x21 ¼ 1.53, p ¼ 0.216; drug  body mass x21 ¼ 0.027, p ¼ 0.870,
drug  reproductive status x21 ¼ 2.52, p ¼ 0.112). No differ-
ences in infection probability were detectable one or two
months after first treatment (one month: drug x21 ¼ 2.33,
p ¼ 0.127, n ¼ 56; two months: treatment x21 ¼ 0.75, p ¼ 0.688,
n ¼ 31), indicating that the effect of Ivermectin on nematodes
was short-lived. Finally, as the results above indicate, not all
treated mice were completely cleared of nematodes (five of
24 treated mice had nematode eggs in faeces one to three
weeks after Ivermectin administration). The following analyses
include these individuals, however, their exclusion made very
little quantitative difference to analyses, and no difference to
our conclusions.
The temporal dynamics of nematode infection probability
also clearly reflected the pattern of Ivermectin treatment
(figure 1b). Notably, mice in the repeated treatment group
showed a reduction in nematode infection probability after
each treatment, whereas those in the single-treatment group
exhibited a treatment effect only immediately after their treat-
ment (figure 1b; single versus repeated nematode infection
probability five to seven weeks after first capture, x21 ¼ 9.87,
p ¼ 0.0017). The most common nematode (Heligmosomoides
polygyrus, accounting for 90% of nematode-infected mice,
42% prevalence overall; table 1) exhibited qualitatively simi-
lar treatment effects (electronic supplementary material,
figure S3), suggesting this species drives the effects on overall
nematode infection probability. Ivermectin had no detectable
effect on nematode infection intensity (egg counts) among
infected individuals over any timescale considered (one to
three weeks post-treatment: F1,13 ¼ 1.17, p ¼ 0.299; one
month after first capture: drug F1,12 ¼ 0.00, p ¼ 0.978; two
months after first capture: treatment F2,19 ¼ 1.81, p ¼ 0.190;
electronic supplementary material, figure S4).
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(b) Effects of anti-nematode treatment on non-target
parasites
As with nematodes, a ZINB model on Eimeria oocyst counts
one to three weeks after treatment provided a better fit than
a standard negative binomial model (Vuong test, p ¼ 0.003).
This model indicated that treatment increased Eimeria
oocyst counts (IRR ¼ 16.45 for treated compared with
untreated mice, normal 95% CI: 5.02, 53.84), but did not sig-
nificantly influence the probability of Eimeria infection (OR ¼
2.12, normal 95% CI: 0.61, 7.43; electronic supplementary
material, section S3a). Eimeria oocyst counts were therefore
over 15 times higher in Ivermectin-treated mice compared
with untreated mice one to three weeks after treatment
(GLM on logged oocyst counts, F1,15 ¼ 8.93, p ¼ 0.009;
figure 1c and electronic supplementary material, table S2).
Post hoc tests showed this effect did not vary significantly
between months, or with host age (adult versus subadult)
or reproductive status (drug month F1,14 ¼ 0.00, p ¼ 0.986;
drug  age F1,13 ¼ 0.37, p ¼ 0.554; drug  reproductive
status F1,13 ¼ 0.02, p ¼ 0.901).
Eimeria parasites also responded rapidly to nematode rein-
fection post-treatment, with Eimeria infection intensity
declining over the same timescale that nematode infection
probability increased: thus, the dynamics of Eimeria spp. inten-
sity mirrored those of nematode infection probability, showing
temporary increases after each Ivermectin treatment, rapidly
returning to pre-perturbation levels as nematodes re-infected
(figure 1d ). Just as for nematodes, no treatment differences in
Eimeria intensity were detectable one or two months after
first capture (one month: drug F1,23¼ 0.10, p ¼ 0.760; two
months: treatment F2,10¼ 1.17, p ¼ 0.348), indicating treat-
ment-induced increases in Eimeria intensity were similarly
short-lived (figure 1d ). Aswith nematode infection probability,
the repeated and single-treatment groups diverged in their
Eimeria intensity dynamics beyond one month after first
capture (figure 1d; single versus repeated Eimeria infection
intensity five to seven weeks after first capture, x21 ¼ 7.11
p ¼ 0.008), which further supports the conclusion that these
Eimeria intensity dynamics were driven by nematode treatment.
Eimeria spp. infection probability was not significantly
altered by treatment over any timescale examined, whether
considering Eimeria species pooled or separately (electronic
supplementary material, figure S5; pooled Eimeria spp.:
within three weeks of last treatment, drug: x21 ¼ 0.76,
p ¼ 0.383, n ¼ 42; one month after first capture: drug
x21 ¼ 1.24, p ¼ 0.265, n ¼ 56; two months after first capture:
treatment x22 ¼ 1.84, p ¼ 0.399, n ¼ 31; p. 0.10 for all drug
or treatment terms in equivalent models for the individual
species E. hungaryensis and E. apionodes).
Examining the Eimeria intensity response in more detail,
we found evidence for species-specificity in this effect. Two
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Figure 1. Effects of the anthelminthic drug Ivermectin on target (nematodes) and non-target (Eimeria) parasites. (a) Effect of Ivermectin administered one to three
weeks previously on nematode infection probability. (b) Nematode infection probability over time since first capture (c) Effect of Ivermectin administered one to
three weeks previously on Eimeria spp. infection intensity. (d ) Eimeria spp. infection intensity over time since first capture. In (b) and (d), arrows indicate times of
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species of Eimeria, differing in their infection site within
the gut, are common in these wood mouse populations:
E. hungaryensis and E. apionodes. Eimeria hungaryensis is
found in the anterior half of the small intestine (where
H. polygyrus, the most common nematode in these mice,
resides; table 1) and predominantly infects enterocytes on
the apex of villi, whereas E. apionodes inhabits a more pos-
terior position in the gut, infecting enterocytes on the sides
of villi or in crypts [30]. Ivermectin-treated mice showed a
stronger increase in E. hungaryensis infection intensity than
in E. apionodes intensity (one to three weeks after last treat-
ment, effect of drug for E. hungaryensis: F1,12 ¼ 13.66, p ¼
0.003, E. apionodes: F1,11 ¼ 6.74, p ¼ 0.025), and the dynamics
of E. hungaryensis intensity mirrored those of nematode infec-
tion probability far more closely than the dynamics of
E. apionodes (compare figure 2 with figure 1b).
No treatment effects on the probability of infection with
blood parasites (either pooled or individual Bartonella spp. or
Trypanosoma grosi) were detected one or two months after treat-
ment (see the electronic supplementary material, figure S6;
pooled Bartonella spp. one month: drug x21¼ 0.02, p ¼ 0.878,
n ¼ 47; two months: treatment x22 ¼ 0.24, p ¼ 0.885, n ¼ 24.
Trypanosoma one month: x21 ¼ 0.19, p ¼ 0.662, n ¼ 46; two
months: x22 ¼ 3.76, p ¼ 0.153, n ¼ 24; p. 0.35 for drug or treat-
ment effects in equivalent models for the individual species
Bartonella taylorii and Bartonella grahamii). Similarly, we found
no effect of nematode treatment on total GI parasite richness,
either including or excluding nematodes, in the subsequent
three weeks (including nematodes: drug x21 ¼ 1.83, p ¼ 0.176,
n ¼ 42; excludingnematodes: drugx21 ¼ 0.17, p ¼ 0.679,n ¼ 42).
There were also no differences in total parasite richness or
GI richness (including or excluding nematodes) at one or two
months after first capture ( p. 0.25, for drug or treatment
terms in all cases) and overall, parasite community richness
was not notably altered by Ivermectin treatment over any
timescale (see the electronic supplementary material, figure
S7). Considering all parasite responses examined, non-target
treatment effects were predominantly weak, with only a few
strong, negative interactions detected (figure 3a), and the distri-
bution of absolute treatment effect sizes for non-target parasite
species was highly skewed towards zero (figure 3b).
4. Discussion
Using a novel drug-based perturbation experimental
approach, we provide a rare experimental demonstration of
interaction between co-infecting parasite species in a wild
vertebrate population, but also show that, overall, the
within-host–parasite communities examined were relatively
stable to drug-based perturbation. Mice given Ivermectin
showed a reduction in nematode infection probability,
while concurrently showing more than a 15-fold increase in
Eimeria intensity compared with controls, suggesting signifi-
cant competition between these two GI parasite taxa.
Moreover, this interaction appeared to be highly dynamic,
with Eimeria intensity rapidly returning to pre-perturbation
levels as nematode re-infection occurred (figure 1).
Although we cannot categorically exclude the possibility
that these effects are caused by a direct positive effect of
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Figure 2. Infection intensity over time since first capture for (a) Eimeria hungaryensis and (b) Eimeria apionodes across Ivermectin treatment groups. While
E. hungaryensis infection intensity increased after each treatment, and more closely mirrored the dynamics of nematode infection probability, E. apionodes was
less affected by treatment. Arrows indicate times of treatment (solid arrows denote repeated treatment; dashed arrows denote single treatment); single-treatment
mice (dashed line, filled squares) are grouped with repeated treatment mice (solid line, filled circles) until four weeks, at which point they become different. Data
are means and s.e.m. from raw data.
rspb.royalsocietypublishing.org
ProcR
SocB
280:20130598
6
the anti-nematode drug on Eimeria parasites, rather than an
indirect effect caused by a reduction in nematodes, a direct
effect seems unlikely for two reasons. First, although macro-
cyclic lactones, including Ivermectin, are known to have non-
specific effects on other organisms besides nematodes,
including arthropods, protozoa and bacteria [31–33], these
tend to be negative, and we can find no instances of direct
positive effects on non-target parasites in the literature,
despite widespread use of Ivermectin in livestock, which
are frequently co-infected. Second, we find evidence for
species-specificity in the effect on Eimeria, which seems
more plausibly attributed to nematode removal than a
species-specific direct effect of Ivermectin. Ivermectin treat-
ment had a much clearer positive effect on E. hungaryensis,
which shares an infection site with the dominant nematode
in this system (H. polygyrus; table 1), than E. apionodes,
which occupies a lower section of the GI tract (figure 2).
These findings strongly suggest the effects of Ivermectin on
Eimeria are due to the drug’s negative effect on H. polygyrus,
and reveal an extremely localized competitive interaction
occurring between a pair of species that inhabit the same sec-
tion of the GI tract. Interestingly, a controlled co-infection
experiment in laboratory mice involving H. polygyrus and
Eimeria vermiformis, a species that inhabits the caecum, did
not find competitive effects as we report here and, if anything,
showed some facilitation of Eimeria by early, but not chronic
stage H. polygyrus infection [34]. This suggests that, as with
free-living systems, species-specific ecological differences are
likely important determinants of interaction mechanism,
direction and strength among parasites.
The mechanism underlying the localized competition we
identified is unknown. However, the fact that we detected an
effect of anti-nematode treatment on Eimeria intensity, but not
on the probability of being Eimeria infected, suggests that
whereas nematodes do not alter susceptibility to acquiring
Eimeria infection per se, they do affect the extent to which
Eimeria parasites replicate once inside the GI tract. We suggest
several potential, non-mutually exclusive mechanisms by
which this could occur. First, it could arise by a resource-
mediated interaction, with H. polygyrus and Eimeria parasites
competing for space or nutrients with the gut. Second, because
H. polygyrus feeds on epithelial tissue [35], in which Eimeria
parasites develop, direct predation of Eimeria parasites by H.
polygyrus may take place. Third, immune mechanisms may be
involved, for example, an immune-mediated increase in entero-
cyte turnover during nematode infection, that could aid the host
in Eimeria expulsion [36].
Although nematodes are expected to be a key interactive
group because of their immunomodulatory effects [9,20,21], in
this experiment the majority of parasites, as well as community
richness as awhole, showed no detectable response to nematode
suppression, producing a distribution of interaction strengths
skewed towards zero. Moreover, non-target parasites that did
respond (Eimeria spp.) quickly returned to pre-perturbation
levels. Hence, these naturally occurring parasite communities
appear to be both resistant and resilient to nematode-targeted
perturbation. Theory suggests several mechanisms could under-
pin such community stability. First, the target parasite group
(nematodes, andH. polygyrus particularly)may have few or rela-
tivelyweak interactionswith co-infecting parasites, although this
would run counter to expectations based on many laboratory
studies [9,10,37]. A second possibility is that shifts in community
structure caused by nematode treatmentmay be extremely short-
lived, and simply not visible over the timescales monitored
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Figure 3. (a) Summary of Ivermectin treatment effects on non-target parasites. Effect size estimates (Hedge’s g) for the effect of treatment on non-target parasite
response variables. Negative g-values indicate suppressive effects of nematodes (treatment resulted in higher infection intensities or infection probability for the
non-target parasite than control mice), positive values indicate the opposite. Effect sizes were calculated either for parasite infection probability (using the odds ratio
to calculate g), or from the difference in mean oocyst counts per gram faeces, on a log scale as used in statistical analyses. (b) Frequency histogram of the absolute
effect sizes shown in (a), showing skew of the distribution towards primarily weak interactions.
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(weeks tomonths). The one non-target responsewe found, invol-
vingEimeria spp.,wasdetectablewithinweeks, butnotmonthsof
treatment, suggesting these parasite communities are extremely
resilient and can recover quickly (within fourweeks) frompertur-
bations. A number of studies on the response of human gut
microbial communities to antibiotic perturbation have documen-
ted similar resilience, whereby communities show notable shifts
in the weeks following treatment but largely rebound to their
original state over months or years [38,39]. Third, it may be that
the structure of within-host–parasite communities themselves
is conducive to stability. In particular, the skewed distribution
of interaction strengths observed here (figure 3b) echoes findings
from food webs of free-living species [40,41], and is known to
promote network stability [7]. Furthermore, stability can also
arise through high modularity or compartmentalization,
where a network comprises modules of strongly interacting
species, with weak or few links betweenmodules [6]. It is note-
worthy in this respect that the only significant interaction
detected here was between two parasites that live in close
proximity to each other. Interestingly, a recent literature-
based network study of human co-infection data found signifi-
cant modularity in the parasite community, with distinct
modules of closely interacting species largely reflecting differ-
ent locations in the body (E. C. Griffiths, A. B. Pedersen,
A. Fenton & O. L. Petchey 2012, unpublished data). Thus, it
may be that although strong interactions between co-infecting
parasites do occur within any given module (e.g. body com-
partment), links to other such groups (e.g. through systemic
immune effects) are rare or weaker, facilitating overall stability
of the network in the face of perturbation.
The drug-based perturbations we used resemble current
anthelmintic treatment programmes in humans and livestock,
in terms of the drug used (Ivermectin), the periodic nature of
treatment [42], efficacy level [43] and observed responses
post-treatment, with rapid helminth reinfection after drug
administration [44,45]. Our study shows, for the first time
in a natural mammalian host–parasite system, how such
treatments may impact the wider parasite community, lead-
ing to unintended responses in the abundance of some co-
infecting parasites, but not in others. We also show how a
community ecology framework can help identify how the
strength, type and arrangement of parasite interactions may
contribute to within-host–parasite community stability, and
pinpoint certain parasite characteristics (e.g. shared location
within the host) that predispose non-target parasites to
respond to treatment. Such perturbation studies on natural
parasite communities provide direct empirical demonstra-
tion of how anthelminthic treatment may impact the wider
parasite community, and can inform our understanding of
whether ‘holistic’ disease control programmes, that seek an
indirect, added benefit of deworming through parasite
interactions [46,47] are likely to achieve their goal.
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